BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26510622)

  • 1. Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design.
    Miglianico M; Nicolaes GA; Neumann D
    J Med Chem; 2016 Apr; 59(7):2879-93. PubMed ID: 26510622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature.
    Giordanetto F; Karis D
    Expert Opin Ther Pat; 2012 Dec; 22(12):1467-77. PubMed ID: 23136886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided drug design for AMP-activated protein kinase activators.
    Wang Z; Huo J; Sun L; Wang Y; Jin H; Yu H; Zhang L; Zhou L
    Curr Comput Aided Drug Des; 2011 Sep; 7(3):214-27. PubMed ID: 21595631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of AMP-activated protein kinase: prospects for computer-aided drug design.
    Kim J; Yang G; Ha J
    Expert Opin Drug Discov; 2017 Jan; 12(1):47-59. PubMed ID: 27797589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
    Popovics P; Frigo DE; Schally AV; Rick FG
    Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK activators: mechanisms of action and physiological activities.
    Kim J; Yang G; Kim Y; Kim J; Ha J
    Exp Mol Med; 2016 Apr; 48(4):e224. PubMed ID: 27034026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP-activated protein kinase modulators: a patent review (2006 - 2010).
    Yun H; Ha J
    Expert Opin Ther Pat; 2011 Jul; 21(7):983-1005. PubMed ID: 21548715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential upstream regulators and downstream targets of AMP-activated kinase signaling during oocyte maturation in a marine worm.
    Stricker SA
    Reproduction; 2011 Jul; 142(1):29-39. PubMed ID: 21474604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK activators--potential therapeutics for metabolic and other diseases.
    Zhou G; Sebhat IK; Zhang BB
    Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene of the month. AMP kinase (PRKAA1).
    Krishan S; Richardson DR; Sahni S
    J Clin Pathol; 2014 Sep; 67(9):758-63. PubMed ID: 24895169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.
    Noda K; Nakajima S; Godo S; Saito H; Ikeda S; Shimizu T; Enkhjargal B; Fukumoto Y; Tsukita S; Yamada T; Katagiri H; Shimokawa H
    PLoS One; 2014; 9(11):e110446. PubMed ID: 25365359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promise and challenges for direct small molecule AMPK activators.
    Olivier S; Foretz M; Viollet B
    Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.
    Ghaffar A; Batool S; Mushtaq G; Kamal MA
    Curr Comput Aided Drug Des; 2017; 13(3):222-233. PubMed ID: 28294049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting AMPK signalling pathway with natural medicines for atherosclerosis therapy: an integration of in silico screening and in vitro assay.
    Ou T; Hou X; Guan S; Dai J; Han W; Li R; Wang W; Qu X; Zhang M
    Nat Prod Res; 2016 Jun; 30(11):1240-7. PubMed ID: 26166578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.
    Dite TA; Langendorf CG; Hoque A; Galic S; Rebello RJ; Ovens AJ; Lindqvist LM; Ngoei KRW; Ling NXY; Furic L; Kemp BE; Scott JW; Oakhill JS
    J Biol Chem; 2018 Jun; 293(23):8874-8885. PubMed ID: 29695504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and signaling by the AMP-activated protein kinase in endothelial cells.
    Fisslthaler B; Fleming I
    Circ Res; 2009 Jul; 105(2):114-27. PubMed ID: 19608989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing a simple model system for binding studies of known and novel inhibitors of AMPK: a therapeutic target for prostate cancer.
    Kumar R; Maurya R; Saran S
    J Biomol Struct Dyn; 2019 Feb; 37(3):781-795. PubMed ID: 29447108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanguinarine is an allosteric activator of AMP-activated protein kinase.
    Choi J; He N; Sung MK; Yang Y; Yoon S
    Biochem Biophys Res Commun; 2011 Sep; 413(2):259-63. PubMed ID: 21884681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AMP-activated protein kinase in cancer therapy.
    Rehman G; Shehzad A; Khan AL; Hamayun M
    Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening methods for AMP-activated protein kinase modulators: a patent review.
    Kim J; Shin J; Ha J
    Expert Opin Ther Pat; 2015 Mar; 25(3):261-77. PubMed ID: 25535089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.